Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Innovative imaging techniques for assessing carotid atherosclerosis

Official title: Carotid Atherosclerosis : Innovative Imaging Biomarkers. Study Case-control

Run by Hospices Civils de Lyon · NCT02748941 · Data updated 2026-11-12

This study tests new imaging methods to see if they can help identify dangerous plaque in the arteries of people with carotid stenosis, particularly to tell the difference between those who have had a stroke and those who haven't.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment77 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Drugs / interventionsradiation
Locations1 site (Bron)
StatusRecruiting
StartedJanuary 12, 2017
Main results expectedFebruary 12, 2027
Study endsFebruary 12, 2027
Registry record updatedApril 3, 2026
Trial IDNCT02748941 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with carotid stenosis of 50% or greater who have experienced a recent stroke or transient ischemic attack.

Probably not a fit

Patients with a modified Rankin scale score greater than 3 or those with serious co-morbid diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates new imaging biomarkers to evaluate carotid atherosclerosis, focusing on the vulnerability of atherosclerotic plaques. It aims to improve the understanding of plaque composition and its relationship to stroke risk by utilizing advanced imaging techniques such as High Resolution MRI and ultrasound examinations. The study includes patients with significant carotid stenosis and aims to differentiate between those who have experienced a stroke and those who have not, thereby enhancing risk assessment and treatment strategies.

Why it matters

Potential benefit: If successful, this study could lead to better risk stratification and management of patients with carotid stenosis, potentially reducing the incidence of strokes.

How similar studies have gone: Other studies have shown promise in using advanced imaging techniques for assessing plaque vulnerability, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Carotid stenosis ≥ 50% NASCET
* Case: ipsilateral carotid stenosis stroke, certified by MRI or CT in the preceding month, with no others causes of stroke
* Control: no clinical sign or MRI hint for a recent stroke
* Signed informed consent form
* Patient affiliated to a social security system or equivalent

Exclusion Criteria:

* Modified Rankin scale \> 3
* Homolateral stroke or TIA \> 1 month
* Medical history of homolateral carotid surgery, cervical radiation, carotid occlusive, homolateral intracranial stenosis, risk of developing arterial thromboembolic events
* Renal failure (creatinine clearance \< 50 ml/min)
* Contraindication to ultrasound (sonovue)
* Contraindication to MRI and its contrast media (Gadolinium)
* Inability to sign informed consent
* Inability to undergo any of the technics (claustrophobia…)
* Serious co-morbid disease, dementia
* Neurological disease with no carotid disease
* Risk of pregnancy or pregnancy or breastfeeding
* Adult under reinforced guardianship or legal guardian
* Patient not understanding French

Where it's running

  • Hospices Civils de Lyon - Service de radiologie
    Bron, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.